NeuroShield is non-invasive, real-time screening of Schizophrenia and Alzheimer’s Disease from EEG signals. A pocketable ESP32 + BioAmp headset, a Conv1D-LSTM model at 94.2% accuracy, and a mobile-first clinical workflow. Screening in minutes, not weeks.
apps/mobile/ with BLE pairing, voice-assisted recording, and patient / caregiver / clinician rolesapps/backend/, web in apps/web/, firmware in firmware/, training in ml/Three steps from headset to risk score.
schizophrenia 0.12 · alzheimer’s 0.08 in the example above.What conditions can NeuroShield detect?
Schizophrenia and Alzheimer’s Disease: simultaneous 0–1 risk scores from one recording via a multi-output network.
How accurate is the AI analysis?
94.2% on validated sets (PhysioNet MMI, TUH, DEED, ADNI, COBRA) with a shared Conv1D-LSTM + attention trunk.
Is the hardware difficult to set up?
No. Dry electrodes, no gel, BLE pairing. Under 2 minutes from box to recording.
Is patient data secure?
On-device processing, end-to-end encryption, explicit consent before anything leaves the device.
Can this work in resource-limited settings?
That’s the point: low-cost portable hardware + AI analysis delivers specialist-level screening with no neurologist on-site.